Survival rates and patient reported outcomes support the use of custom cement-over megaprosthesis (CCOM) in complex revision lower limb arthroplasty.

Asad Ali,Iftikar Ahmed,Alex Shearman,Robert McCulloch,Richard Carrington,John Skinner
DOI: https://doi.org/10.1016/j.arth.2024.01.028
IF: 4.435
2024-01-19
The Journal of Arthroplasty
Abstract:Introduction Patients presenting with periprosthetic osteolysis or fracture between ipsilateral hip and knee arthroplasties are challenging to treat successfully. Long-stem implants, osteopenic bones, and patient comorbidities all represent considerable surgical challenges. Poor results of fracture fixation in this group, coupled with the desire to retain well-performing implants and minimize soft-tissue trauma led to the development of the custom cement-over megaprostheses (CCOM). The aims of the study were to evaluate implant survivals, complications, and patient outcomes in those undergoing CCOM within our institution. Methods A retrospective analysis of patients undergoing CCOM between 2002 and 2022 was performed. We studied 34 cases in 33 patients of which one patient underwent staged bilateral surgery with 26 women and 8 men. Indications included trauma (16), failure of implants / aseptic loosening (9), or joint pathology. The mean Charlson comorbidity index (CCI) was 3.5 (range, 0 to 8). All patients were followed up (mean 75 months (range, 9 to 170)) at 6 weeks, 6 months, 1 year, and annually thereafter. The visual analogue score (VAS), EuroQol Group 5 Dimension Score (EuroQol-5D-3L) and Musculoskeletal Tumour Society Score (MSTS) scores were collected at 1 year. Results There was overall implant survival defined by the primary outcome (all-cause revision of the implant at any time point) at 12 months of 97% (32 of 33). In surviving patients, implant survival was 90% (18 of 20) and all 7 survived at 5 and 10 years, respectively. Implant survival including those in the primary outcome group and those free of infection at 12 months was 84.8% (28 of 33) and in surviving patients, implant survival was 70% (14 of 20) and 7 out of 7 at 5 and 10 years, respectively. Conclusions The CCOM technique demonstrates good implant survivorships and satisfactory patient-reported outcomes in complex, often frail patients who have compromised bone stock. This series confirms the technique as an established alternative to total femoral replacement in these cases.
orthopedics
What problem does this paper attempt to address?